Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1993 Sep;56(9):943–946. doi: 10.1136/jnnp.56.9.943

Hypersusceptibility to chemicals: risk factors for neurological disease?

A Williams
PMCID: PMC489726  PMID: 8410033

Full text

PDF
943

Images in this article

946Image
on p.946

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bock K. W. Metabolic polymorphisms affecting activation of toxic and mutagenic arylamines. Trends Pharmacol Sci. 1992 Jun;13(6):223–226. doi: 10.1016/0165-6147(92)90068-h. [DOI] [PubMed] [Google Scholar]
  2. Bonuccelli U., Piccini P., Del Dotto P., Pacifici G. M., Corsini G. U., Muratorio A. Platelet monoamine oxidase B activity in parkinsonian patients. J Neurol Neurosurg Psychiatry. 1990 Oct;53(10):854–855. doi: 10.1136/jnnp.53.10.854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chiba K., Trevor A., Castagnoli N., Jr Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem Biophys Res Commun. 1984 Apr 30;120(2):574–578. doi: 10.1016/0006-291x(84)91293-2. [DOI] [PubMed] [Google Scholar]
  4. Choi D. W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988 Oct;1(8):623–634. doi: 10.1016/0896-6273(88)90162-6. [DOI] [PubMed] [Google Scholar]
  5. Davis G. C., Williams A. C., Markey S. P., Ebert M. H., Caine E. D., Reichert C. M., Kopin I. J. Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res. 1979 Dec;1(3):249–254. doi: 10.1016/0165-1781(79)90006-4. [DOI] [PubMed] [Google Scholar]
  6. Ding X. X., Coon M. J. Purification and characterization of two unique forms of cytochrome P-450 from rabbit nasal microsomes. Biochemistry. 1988 Nov 1;27(22):8330–8337. doi: 10.1021/bi00422a007. [DOI] [PubMed] [Google Scholar]
  7. Gonzalez F. J. The molecular biology of cytochrome P450s. Pharmacol Rev. 1988 Dec;40(4):243–288. [PubMed] [Google Scholar]
  8. Halliwell B., Gutteridge J. M., Cross C. E. Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med. 1992 Jun;119(6):598–620. [PubMed] [Google Scholar]
  9. Heafield M. T., Fearn S., Steventon G. B., Waring R. H., Williams A. C., Sturman S. G. Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease. Neurosci Lett. 1990 Mar 2;110(1-2):216–220. doi: 10.1016/0304-3940(90)90814-p. [DOI] [PubMed] [Google Scholar]
  10. Heikkila R. E., Nicklas W. J., Vyas I., Duvoisin R. C. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Neurosci Lett. 1985 Dec 18;62(3):389–394. doi: 10.1016/0304-3940(85)90580-4. [DOI] [PubMed] [Google Scholar]
  11. Konradi C., Ozelius L., Breakefield X. O. Highly polymorphic (GT)n repeat sequence in intron II of the human MAOB gene. Genomics. 1992 Jan;12(1):176–177. doi: 10.1016/0888-7543(92)90426-s. [DOI] [PubMed] [Google Scholar]
  12. Kontos H. A. Oxygen radicals in CNS damage. Chem Biol Interact. 1989;72(3):229–255. doi: 10.1016/0009-2797(89)90001-x. [DOI] [PubMed] [Google Scholar]
  13. Langston J. W., Ballard P., Tetrud J. W., Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983 Feb 25;219(4587):979–980. doi: 10.1126/science.6823561. [DOI] [PubMed] [Google Scholar]
  14. MOTULSKY A. G. PHARMACOGENETICS. Prog Med Genet. 1964;23:49–74. [PubMed] [Google Scholar]
  15. Mahgoub A., Idle J. R., Dring L. G., Lancaster R., Smith R. L. Polymorphic hydroxylation of Debrisoquine in man. Lancet. 1977 Sep 17;2(8038):584–586. doi: 10.1016/s0140-6736(77)91430-1. [DOI] [PubMed] [Google Scholar]
  16. Nebert D. W., Jaiswal A. K., Meyer U. A., Gonzalez F. J. Human P-450 genes: evolution, regulation and possible role in carcinogenesis. Biochem Soc Trans. 1987 Aug;15(4):586–589. doi: 10.1042/bst0150586. [DOI] [PubMed] [Google Scholar]
  17. Olanow C. W. Oxidation reactions in Parkinson's disease. Neurology. 1990 Oct;40(10 Suppl 3):suppl 32–39. [PubMed] [Google Scholar]
  18. Olney J. W. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science. 1969 May 9;164(3880):719–721. doi: 10.1126/science.164.3880.719. [DOI] [PubMed] [Google Scholar]
  19. PETERS R. A. Lethal synthesis. Proc R Soc Lond B Biol Sci. 1952 Feb 28;139(895):143–170. doi: 10.1098/rspb.1952.0001. [DOI] [PubMed] [Google Scholar]
  20. Price R. A., Keith R. A., Spielman R. S., Weinshilboum R. M. Major gene polymorphism for human erythrocyte (RBC) thiol methyltransferase (TMT). Genet Epidemiol. 1989;6(6):651–662. doi: 10.1002/gepi.1370060602. [DOI] [PubMed] [Google Scholar]
  21. Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J. P., Deng H. X. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993 Mar 4;362(6415):59–62. doi: 10.1038/362059a0. [DOI] [PubMed] [Google Scholar]
  22. Rothman S. M. Synaptic activity mediates death of hypoxic neurons. Science. 1983 Apr 29;220(4596):536–537. doi: 10.1126/science.6836300. [DOI] [PubMed] [Google Scholar]
  23. Rothman S. Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J Neurosci. 1984 Jul;4(7):1884–1891. doi: 10.1523/JNEUROSCI.04-07-01884.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Schapira A. H., Cooper J. M., Dexter D., Clark J. B., Jenner P., Marsden C. D. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem. 1990 Mar;54(3):823–827. doi: 10.1111/j.1471-4159.1990.tb02325.x. [DOI] [PubMed] [Google Scholar]
  25. Smith C. A., Gough A. C., Leigh P. N., Summers B. A., Harding A. E., Maraganore D. M., Sturman S. G., Schapira A. H., Williams A. C., Maranganore D. M. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet. 1992 Jun 6;339(8806):1375–1377. doi: 10.1016/0140-6736(92)91196-f. [DOI] [PubMed] [Google Scholar]
  26. Steventon G. B., Heafield M. T., Waring R. H., Williams A. C. Xenobiotic metabolism in Parkinson's disease. Neurology. 1989 Jul;39(7):883–887. doi: 10.1212/wnl.39.7.883. [DOI] [PubMed] [Google Scholar]
  27. Steventon G., Williams A. C., Waring R. H., Pall H. S., Adams D. Xenobiotic metabolism in motor neuron disease. Lancet. 1988 Sep 17;2(8612):644–647. doi: 10.1016/s0140-6736(88)90467-9. [DOI] [PubMed] [Google Scholar]
  28. Teitelbaum J. S., Zatorre R. J., Carpenter S., Gendron D., Evans A. C., Gjedde A., Cashman N. R. Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. N Engl J Med. 1990 Jun 21;322(25):1781–1787. doi: 10.1056/NEJM199006213222505. [DOI] [PubMed] [Google Scholar]
  29. Waring R. H., Steventon G. B., Sturman S. G., Heafield M. T., Smith M. C., Williams A. C. S-methylation in motorneuron disease and Parkinson's disease. Lancet. 1989 Aug 12;2(8659):356–357. doi: 10.1016/s0140-6736(89)90538-2. [DOI] [PubMed] [Google Scholar]
  30. Weber W. W., Hein D. W. N-acetylation pharmacogenetics. Pharmacol Rev. 1985 Mar;37(1):25–79. [PubMed] [Google Scholar]
  31. Widner H., Tetrud J., Rehncrona S., Snow B., Brundin P., Gustavii B., Björklund A., Lindvall O., Langston J. W. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) N Engl J Med. 1992 Nov 26;327(22):1556–1563. doi: 10.1056/NEJM199211263272203. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES